Perspective Therapeutics (CATX) Total Liabilities (2011 - 2026)

Perspective Therapeutics (CATX) has 16 years of Total Liabilities data on file, last reported at $63.3 million in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities rose 41.67% year-over-year to $63.3 million; the trailing twelve-month figure through Mar 2026 stood at $63.3 million (up 41.67% YoY), and the FY2025 full-year result was $59.9 million, up 18.85% from the prior year.
• Total Liabilities rose to $63.3 million in Q1 2026, from $59.9 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $63.3 million in Q1 2026 to a low of $2.9 million in Q1 2022.
• A 5-year average of $31.9 million and a median of $44.7 million in 2025 frame the typical range for Total Liabilities.
• Across the five-year window, Total Liabilities soared 558.51% in 2023 and dropped 16.07% in 2025, its largest moves.
• Tracing CATX's Total Liabilities over 5 years: stood at $3.4 million in 2022, then soared by 558.51% to $22.7 million in 2023, then surged by 122.05% to $50.4 million in 2024, then increased by 18.85% to $59.9 million in 2025, then grew by 5.66% to $63.3 million in 2026.
• Business Quant data shows CATX's Total Liabilities at $63.3 million in Q1 2026, $59.9 million in Q4 2025, and $52.6 million in Q3 2025.